| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
94,014,000 |
| Market
Cap: |
2.04(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$11.39 - $24.57 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Syndax Pharmaceuticals is a clinical-stage biopharmaceutical company developing a pipeline of cancer therapies. Co.'s two primary product candidates are, SNDX-5613 and SNDX-6352 or axatilimab. Co. is developing SNDX-5613, targeting the binding interaction of menin with the mixed lineage leukemia 1 (MLL1) protein for the treatment of MLL-rearranged acute leukemias and nucleophosmin 1 mutant acute myeloid leukemia, as well as axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 receptor. Co. has a collaboration and license agreement with Incyte Corporation for the development and commercialization of axatilimab.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
242,142 |
1,322,814 |
| Total Sell Value |
$0 |
$0 |
$4,873,574 |
$30,131,894 |
| Total People Sold |
0 |
0 |
3 |
8 |
| Total Sell Transactions |
0 |
0 |
5 |
37 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Egros Fabrice |
|
– • – |
2021-11-18 |
4 |
OE |
$7.88 |
$125,256 |
D/D |
14,030 |
16,030 |
|
- |
|
| Metzger Michael A |
President and COO |
• • – |
2021-10-26 |
4 |
AS |
$19.20 |
$312,825 |
D/D |
(16,296) |
17,659 |
|
-9% |
|
| Metzger Michael A |
President and COO |
• • – |
2021-10-26 |
4 |
OE |
$7.20 |
$117,331 |
D/D |
16,296 |
33,955 |
|
- |
|
| Metzger Michael A |
President and COO |
• • – |
2021-10-25 |
4 |
AS |
$19.13 |
$855,335 |
D/D |
(44,704) |
17,659 |
|
-10% |
|
| Metzger Michael A |
President and COO |
• • – |
2021-10-25 |
4 |
OE |
$7.20 |
$321,869 |
D/D |
44,704 |
62,363 |
|
- |
|
| Podlesak Dennis |
|
– • – |
2021-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
463 |
43,763 |
|
- |
|
| Metzger Michael A |
President and COO |
• • – |
2021-09-27 |
4 |
AS |
$19.51 |
$476,832 |
D/D |
(24,437) |
17,659 |
|
-21% |
|
| Metzger Michael A |
President and COO |
• • – |
2021-09-27 |
4 |
OE |
$7.20 |
$175,946 |
D/D |
24,437 |
42,096 |
|
- |
|
| Metzger Michael A |
President and COO |
• • – |
2021-09-22 |
4 |
AS |
$19.02 |
$5,706 |
D/D |
(300) |
17,659 |
|
-16% |
|
| Metzger Michael A |
President and COO |
• • – |
2021-09-22 |
4 |
OE |
$7.20 |
$2,160 |
D/D |
300 |
17,959 |
|
- |
|
| Metzger Michael A |
President and COO |
• • – |
2021-09-21 |
4 |
AS |
$19.16 |
$92,108 |
D/D |
(4,808) |
17,659 |
|
-11% |
|
| Metzger Michael A |
President and COO |
• • – |
2021-09-21 |
4 |
OE |
$7.20 |
$34,618 |
D/D |
4,808 |
22,467 |
|
- |
|
| Metzger Michael A |
President and COO |
• • – |
2021-09-20 |
4 |
AS |
$19.24 |
$605,046 |
D/D |
(31,455) |
17,659 |
|
-13% |
|
| Metzger Michael A |
President and COO |
• • – |
2021-09-20 |
4 |
OE |
$7.20 |
$226,476 |
D/D |
31,455 |
49,114 |
|
- |
|
| Morrison Briggs |
Chief Executive Officer |
• • – |
2021-09-20 |
4 |
AS |
$20.00 |
$1,000 |
D/D |
(50) |
48,336 |
|
-13% |
|
| Morrison Briggs |
Chief Executive Officer |
• • – |
2021-09-20 |
4 |
OE |
$7.20 |
$360 |
D/D |
50 |
48,386 |
|
- |
|
| Morrison Briggs |
Chief Executive Officer |
• • – |
2021-09-17 |
4 |
AS |
$20.07 |
$1,410,018 |
D/D |
(70,262) |
48,336 |
|
-21% |
|
| Morrison Briggs |
Chief Executive Officer |
• • – |
2021-09-17 |
4 |
OE |
$7.20 |
$505,886 |
D/D |
70,262 |
118,598 |
|
- |
|
| Metzger Michael A |
President and COO |
• • – |
2021-09-14 |
4 |
AS |
$19.15 |
$849,394 |
D/D |
(44,349) |
17,659 |
|
-13% |
|
| Metzger Michael A |
President and COO |
• • – |
2021-09-14 |
4 |
OE |
$7.20 |
$319,313 |
D/D |
44,349 |
62,008 |
|
- |
|
| Metzger Michael A |
President and COO |
• • – |
2021-09-13 |
4 |
AS |
$19.02 |
$316,639 |
D/D |
(16,651) |
17,659 |
|
-11% |
|
| Metzger Michael A |
President and COO |
• • – |
2021-09-13 |
4 |
OE |
$7.20 |
$119,887 |
D/D |
16,651 |
34,310 |
|
- |
|
| Egros Fabrice |
|
– • – |
2021-08-18 |
4 |
AS |
$15.75 |
$246,328 |
D/D |
(15,635) |
16,000 |
|
35% |
|
| Egros Fabrice |
|
– • – |
2021-08-18 |
4 |
OE |
$7.88 |
$123,204 |
D/D |
15,635 |
31,635 |
|
- |
|
| Egros Fabrice |
|
– • – |
2021-05-18 |
4 |
AS |
$18.65 |
$253,783 |
D/D |
(13,609) |
16,000 |
|
7% |
|
208 Records found
|
|
Page 6 of 9 |
|
|
0.22 (1%) 
